News

Cuantum opens a one-million euros funding round

The company, located at the Eureka building of the UAB Research Park, designs, develops, manufactures, and commercialises cyanoacrylate adhesives for cosmetic and medical applications. With the increase in capital, Cuantum wants to extend their commercial strategy and open new markets for their products.

Cuantum Medical Cosmetics is a company focused on the development, fabrication, and commercialisation of medical adhesives with applications in the fields of medicine, veterinary medicine, and cosmetics. They offer efficient, quick, and simple solutions that help to suture and close wounds and skin lacerations and improve many of the techniques used on beauty treatments.

The company, founded in 2015 by Ramon Bacardit and Ferran Pujol, has opened a funding round of one million euros through the crowdfunding platform Capital Cell with the goal of opening the commercialisation of their products to new markets. As of today, they have collected 46% of their goal, with more than 70 investors.

The company has a portfolio of 7 CE-marked tissue adhesives that are certified for free sale throughout the European Union and cover consumer, emergency room, general surgery, and dental applications. “Our adhesives replace staples, stitches, sutures, and plasters and have demonstrated the ability to close a wound in just 30 seconds,"  explains Ruben Sáez, CTO of Cuantum.

Moreover, the company has registered, through partners, some of their products in international markets such as Mexico, Saudi Arabia, South Korea, or Egypt, and is currently evaluating the registration of tissue adhesives with the FDA for marketing in the United States. The increase in current capital will allow them to extend the commercial strategy and consolidate their foreseen growth over the next few years.

Since their foundation, Cuantum has reached public funding through different projects (Retos-Colaboración 2016, Neotec 2018, PID 2020, Misiones 2020) with a global budget of over 2 million euros. Last year, the company closed with over a million euros in sales.